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Background: Decompression surgery for lumbar spinal stenosis (LSS) is the most common 45 
spinal procedure in the elderly. To avoid persisting low back pain, adding arthrodesis has 46 
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 2 
been recommended, especially if there is a coexisting degenerative spondylolisthesis. 1 
However, this strategy remains controversial, resulting in practice-based variation.  2 
Purpose: To evaluate in a pragmatic study if surgical selection criteria and variation in use of 3 
arthrodesis in three Scandinavian countries can be linked to variation in treatment 4 
effectiveness.  5 
Study design: An observational study based on a combined cohort from the national spine 6 
registries of Norway, Sweden, and Denmark. 7 
Patient Sample: Patients aged 50 and higher operated 2011–2013 for LSS were included. 8 
Outcome Measures: Patient-reported outcome measures (PROMs) Oswestry disability index 9 
(ODI) (primary outcome), numeric rating scale (NRS) for leg pain and back pain, and health-10 
related quality of life (EQ-5D). Analysis included case-mix adjustment. In addition, we report 11 
differences in hospital stay. 12 
Methods: Analyses of baseline data were done by analysis of variance (ANOVA), Chi-13 
square, or logistic regression tests. The comparisons of the mean changes of PROMs at one-14 
year follow-up between the countries were done by ANOVA (crude) and analyses of 15 
covariance (ANCOVA, case mix adjustment). There are no conflicts of interest. 16 
Funding was received from the Danish Society of Spinal Surgery ($5,925), the Northern 17 
Norway Regional Health Authority ($5,925) and from Swedish Association of Local 18 
Authorities and Regions ($11,885). The sponsor had no role in the acquisition of data, 19 
analysis, or preparation of the manuscript.   20 
Results: Out of 14,223 included patients, 10,890 (77%) responded at one-year follow-up. 21 
Apart from fewer smokers in Sweden and higher comorbidity rate in Norway, baseline 22 
characteristics were similar. The rate of additional fusion surgery (patients without, with 23 
spondylolisthesis) was: Norway 11% (4%, 47%), Sweden 21% (9%, 56%) and Denmark 28% 24 
(15%, 88%). At one-year follow-up the mean improvement for ODI (95%CI) was: Norway 18 25 
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(17 to 18), Sweden 17 (17 to 18), and Denmark 18 (17 to 19). Patients operated with 1 
arthrodesis had prolonged hospital stay.  2 
Conclusions: Real life data from three national spine registers showed similar indications for 3 
decompression surgery, but significant differences in the use of concomitant arthrodesis in 4 
Scandinavia. Additional arthrodesis was not associated with better treatment effectiveness. 5 
 6 
Keywords: lumbar spinal stenosis, spine registry, decompressive surgery, case mix 7 
adjustment, spine fusion, spine arthrodesis 8 
 9 
INTRODUCTION 10 
Low back pain is the leading specific cause for years lived with disability worldwide [1]. 11 
Narrowing of the spinal canal, known as lumbar spinal stenosis (LSS) is the most common 12 
indication for spine surgery in the elderly population. LSS typically causes symptoms of low 13 
back pain, lower extremity pain and numbness due to nerve root compression, resulting in 14 
walking disability [2]. Decompression of the spinal canal is the key objective of surgery and 15 
is considered superior to non-surgical treatment for patients with moderate to severe LSS [3]. 16 
Often, there is a coexisting degenerative spondylolisthesis, i.e. a slip of one vertebra in 17 
relation to another. Traditionally, this radiological finding has been regarded as a sign of 18 
segmental instability. Although this interpretation has been disputed, adding surgical fusion 19 
between the two vertebrae (arthrodesis) in addition to decompression has been recommended 20 
to prevent persisting back pain [4, 5]. However, several recent studies found no effect of 21 
additional arthrodesis surgery [6-8]. Due to lack of uniform guidelines in this field, there is a 22 
large and possibly unwarranted practice variation in the use of additional arthrodesis [9, 10]. 23 
In a recent study fusion rate (with, without spondylolisthesis) was considerably lower in 24 
university hospitals of Norway (44%, 6%) compare to Boston, US (95%, 29%) [11]. In the 25 
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US, rising costs connected to arthrodesis of the lumbar spine have attracted the attention of 1 
health providers and policy makers. In 2011 spinal fusion accounted for the highest aggregate 2 
hospital costs of any surgical procedure performed in U.S. hospitals ($12.8 billion) [12]. 3 
The higher cost connected to arthrodesis surgery should be justified by better patient-reported 4 
outcome. In 2015, the International consortium for health outcome measurement (ICHOM) 5 
recommended a set of patient-reported outcome measures (PROMs) for evaluating surgical 6 
treatment of degenerative conditions in the lumbar spine to facilitate clinical studies across 7 
nations and centers [13]. The national spine surgery registries of Norway, Sweden, and 8 
Denmark were among the collaborators. Scandinavian countries are characterized by a 9 
genetically homogenous population, similar social security systems, and public based health 10 
care and health insurance systems, facilitating comparative studies [14]. The incidence of 11 
surgically treated lumbar spinal stenosis is similar (30-35/100 000/year) based on imputed 12 
numbers from the registries. Clinical registries collecting data from everyday practice can 13 
evaluate different treatment strategies by linking practice-based variation to patient-reported 14 
outcomes in a pragmatic trail. Unlike randomized controlled trials, registry-based studies 15 
allow for surgeons and patients preferences to be included in the process prior to surgery, as 16 
in the “real world” of clinical practice, and adds external validity to already published data 17 
from randomized controlled trails [15]. Such information may aid in guideline development 18 
and resource allocation.  19 
The aims of this observational multinational register study were to compare practice-based 20 
variation in surgical treatment of LSS by; (1) surgical selection criteria (preoperative patient 21 
characteristics), (2) type of surgery (decompression only or decompression plus arthrodesis), 22 
and (3) to assess if practice-based variations were associated to different patient-reported 23 
outcomes (crude and case mix adjusted), in a large combined registry cohort from three 24 
Scandinavian countries.  25 
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METHODS 1 
This observational study reviews data from the national spine registries of Norway 2 
(NORspine), Sweden (Swespine), and Denmark (DaneSpine). Eligible patients were aged 50 3 
or older with no history of previous lumbar spine surgery, operated for LSS during 2011, 4 
2012, or 2013. At baseline, the surgeon recorded diagnosis and treatment according to 5 
standardized questionnaire.  The diagnosis of LSS was based on the surgeons’ clinical 6 
judgment and assessment of magnetic resonance imaging, MRI. Concomitant 7 
spondylolisthesis is defined as a visible slip, 3 mm or more, of one vertebra in relation to 8 
another. All patients received surgical decompression, some with concomitant arthrodesis.  9 
The registers  10 
All three national spine registries are designed for The 11 
participation is voluntary for the surgical departments as well as the patient. At admission for 12 
surgery (baseline), the patient reports data on demographics, risk factors, and PROMs. During 13 
the hospital stay, the surgeon records diagnosis, type of surgery, and perioperative 14 
complications uestionnaires 15 
 16 
The treating hospitals are not involved in follow up. The oldest registry, Swespine, has 17 
included patients since 1998. Swespine covers approximately 95% of the surgical units in 18 
Sweden. Completeness, the proportion of operated patients reported to Swespine, was 19 
approximately 75%. NORspine is based on the concept of Swespine, and was founded in 20 
2007 (coverage 95%, completeness of 65%). DaneSpine was acquired by the Danish Spine 21 
Society from the Swedish Society of Spinal Surgeons in 2009 and has successively been 22 
implemented (coverage 80%, completeness 62%).  23 
Patient-reported outcome measures (PROMs) 24 
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 6 
set of PROMs [13]. 1 
Oswestry Disability Index (ODI, version 2.1), a standard for measuring back pain related 2 
disability, ranging from 0 (no disability) to 100 (bedridden) [16]. 3 
numeric rating scales (NRS) for back and leg pain, 4 
ranging from 0 (no pain) to 10 (worst conceivable pain). 5 
ranging from -0.596 to 1, with higher scores 6 
indicating better quality of life. 7 
NORspine used the NRS for leg and back pain, while Swespine and DaneSpine used the 8 
Visual Analogue Scale (VAS), ranging from 0-100. Conversion to NRS was done by dividing 9 
the VAS score by ten with a stochastic approximation of decimals to the closest integer.  10 
Data handling and analysis 11 
Anonymous data from the three registers were pooled and stored on the Swespine data server. 12 
Missing or out of range data on gender, age, height, or weight were deleted (Figure 1). In case 13 
of missing outcome data case exclusion analysis by analysis was used. Furthermore, cases 14 
with missing date of surgery and follow-up were excluded.  15 
Comparisons of data 16 
Analysis of baseline data included PROM-scores, age at date of surgery, gender, height, 17 
weight, smoking habits, sick leave, and duration of leg and back pain presented as mean (95% 18 
confidence interval), or number (%). Variables were analyzed by analysis of variance 19 
(ANOVA), Chi-square, or logistic regression tests. The comparisons of the mean changes of 20 
PROMs at one-year follow-up were done by ANOVA (crude) and analyses of covariance 21 
(ANCOVA, case mix adjustment). The minimal clinically important change (MCIC) is the 22 
minimal PROM score change that is perceived as meaningful by individual patients, 23 
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 7 
irrespective of statistical significance level. The MCIC was defined as 15 for ODI and 2.0 for 1 
NRS back pain and leg pain, and 0.15 for EQ-5D [17-19] within groups. To compare 2 
clinically meaningful differences in outcomes between groups, we compared the percentage 3 
of patients achieving at least 30% improvement of ODI, and NRS back pain and leg pain [18]. 4 
The absolute 12 months follow up score defining a patient acceptable symptom state was set 5 
to ODI ≤ 22 [20]. 6 
 7 
Sample size   8 
Due to the large sample size (n>10,000), ODI differences as small as 2 points between the 9 
groups would be reported significant (power 90%, significance level 5%), i.e. far below what 10 
is considered as clinically relevant [16].  11 
Non-response analysis 12 
A non-response analysis was performed by comparing all available baseline variables 13 
between those who responded to the one-year follow-up with those who did not.  14 
Ethics 15 
This study was approved by ethical review boards in Norway (REC South-east B: 16 
2014/2219), Sweden (Dnr 2015/181-31), and Denmark (Projekt-ID: S-20160091). It was 17 
conducted and reported in accordance with the Strengthening the Reporting of Observational 18 
studies in Epidemiology (STROBE) checklist and the study protocol, available at 19 
clinicaltrails.gov (ID: NCT02897947). 20 
Funding 21 
Funding was received from the Danish Society of Spinal Surgery ($5,925), the Northern 22 
Norway Regional Health Authority ($5,925) and from Swedish Association of Local 23 
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 8 
Authorities and Regions ($11,885). The funding sources had no role in the study design, 1 
analysis, and interpretation of data, in the writing of the report, and in the decision to submit 2 
the paper for publication.  3 
Conflict of interest  4 
All authors declare: no support from any organisation for the submitted work; no financial 5 
relationships with any organisations that might have an interest in the submitted work in the 6 
previous three years; no other relationships or activities that could appear to have influenced 7 




At baseline 14223 were included (Norway:  n =3173, Sweden: n = 7389, and Denmark: n = 12 
3661). At one-year follow-up, 10890 (77%) responded (Norway:  n =2559 (81%), Sweden: n 13 
= 5990 (81%), and Denmark: n = 2341 (64%)). Figure 1 shows the exclusion flowchart. 14 
Gender, age, and BMI were similar in the three countries. Fewer were smoking in Sweden, 15 
and a higher comorbidity rate was found in Norway (Table 1).  16 
Mean baseline disability (ODI (95%CI)) was slightly worse in Sweden (44 (43 to 44)), 17 
compared to Denmark (41 (40 to 41)) and Norway (40 (39 to 40)). Health related quality of 18 
life (EQ-5D ±SD) was better in Denmark (0.42 (0.41 to 0.43) vs. Sweden (0.37 (0.36 to 0.38)) 19 
and Norway (0.37 (0.36 to 0.39)). Accordingly, NRS leg pain and back pain intensity were 20 
less in Denmark.  In this study, the non-responders at one year follow-up (n= 3333) were 21 
slightly younger and more often smokers, but otherwise similar to the responders (n=10890) 22 
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 9 
at baseline (Table 2). Multiple levels surgery (two, three levels) was less frequent in Norway 1 
(30%, 6%), than in Sweden (34%, 12%) and Denmark (35%, 12%). 2 
Rate of concomitant arthrodesis 3 
The rate of concomitant arthrodesis was significantly different between the three countries: 4 
Norway 11%, Sweden 21%, and Denmark 28%. For the subgroup of patients with 5 
concomitant spondylolisthesis, the rate of arthrodesis was higher: Norway 47%, Sweden 56% 6 
and Denmark 88% (Figure 2).  7 
Perioperative complications and differences in days at hospital 8 
The frequency of dural tear was: Norway 4.8%, Sweden 5.7%, and Denmark 5.3%, p=0.088. 9 
The frequency of excessive bleeding was: Norway 0.16%, Sweden 0.45%, and Denmark 10 
0.30%, p=0.058 the frequency of nerve root injury was: Norway 0.16%, Sweden 0.09%, and 11 
Denmark 0.03%, p=0.204. The overall rate of perioperative complications was: Norway 12 
5.5%, Sweden 6.2%, and Denmark 5.0%, p=0.033. In the combined cohorts the in hospital 13 
surgeon reported complication rate was 5.8% for both decompression only and decompression 14 
with additional arthrodesis. 15 
In Norway, the mean number of days at hospital (SD) (day 1; day of admission) for patients 16 
operated with decompression alone compared to decompression plus arthrodesis was 3.0 (2.8) 17 
vs. 7.3 (3.9). In Sweden (day 1; day of admission) the corresponding numbers were 3.6 (3.5) 18 
vs. 5.3 (3.1) and in Denmark (day 1; day of operation) 2.0 (1.8) vs. 4.7 (3.2). 19 
Outcome at one year 20 
At one-year follow-up the mean improvement for ODI (95%CI) was in Norway 18 (17 to 18), 21 
Sweden 17 (17 to 18) and Denmark 18 (17 to 19). In the case-mix analysis adjusted for age, 22 
gender, BMI, smoking, any comorbidity, and the preoperative value of ODI, the 23 
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corresponding values were 16 (16 to 17), 18 (18 to 19), and 17 (17 to 17) (Table 3). A MCIC-1 
value of 30% improvement of ODI was achieved by 58% in Norway, 53% in Sweden and 2 
50% in Denmark, (p<0.001). ODI score 22 or below was achieved by 64% in Norway, 64% in 3 
Sweden and 64% in Denmark (p=0.837). There were no differences in rate of patients 4 
reaching MCIC for leg pain or back pain between the countries (Table 3).  5 
Subgroup analysis  6 
In the combined cohort, patients operated for LSS without spondylolisthesis had an 7 
unadjusted mean ODI improvement (95%CI) of 17 (17 to 18) in the decompression only 8 
group and 18 (17 to 20) in the decompression plus arthrodesis group. Using case mix adjusted 9 
analyses the corresponding numbers were 17 (17 to 18) and 19 (18 to 20). For patients with a 10 
concomitant spondylolisthesis, the improvement in unadjusted mean (95%CI) was 17 (16 to 11 
18) in the decompression only group and 20 (19 to 21) in the decompression and arthrodesis 12 
group. Corresponding case mixed values were 17 (17 to 18) and 18 (18 to 19) (Table 4). 13 
When comparing outcomes of patients with and without spondylolisthesis between the three 14 
countries, no clinically relevant differences were found (Figure 3). 15 
 16 
DISCUSSION 17 
To our knowledge, this represents the worlds’ largest observational study of patients operated 18 
for LSS, and the first comparison across countries using the ICHOM-recommended core data 19 
set. Even though the selection criteria for surgery in terms of demographic characteristics, 20 
pain intensity and disability were similar, we found a significant practice variation, i.e. use of 21 
additional arthrodesis surgery was almost three times higher in Denmark and two times higher 22 
in Sweden as compared to Norway (Figure 2). This demonstrates that even in homogenous 23 
populations with similar health care systems the treatment traditions can vary considerably. 24 
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We observed longer hospital stay among patients operated with additional arthrodesis, which, 1 
together with the implants used, indicates higher cost but no better treatment effectiveness.  2 
 3 
Our findings are in accordance with a recent Swedish randomized controlled trial (RCT) by 4 
Försth et al. of 247 patients showing that additional arthrodesis neither reduced reoperation 5 
rates nor improved clinical outcomes (ODI) [6]. A randomized controlled trial from the US by 6 
Ghogawala et al. involving 66 patients found that additional arthrodesis surgery for LSS with 7 
mild spondylolisthesis reduced the risk for reoperation and gave larger improvement of 8 
physical health–related quality of life (generic SF 36) than laminectomy alone [7]. For all 9 
other outcomes, including the disease specific ODI, no difference was found. This study has 10 
been heavily criticized, also because reoperation rate during follow-up was remarkably high 11 
[21]. Higher frequency of reoperations in the US may however reflect potential cultural 12 
differences in patient expectations, difference in treatment traditions and incentives for 13 
arthrodesis surgery driven by health insurance and reimbursement programs compare to those 14 
found in countries like Sweden. 15 
 16 
A Swedish non-randomized registry study of 5390 LSS patients with or without 17 
spondylolisthesis operated between 1998 and 2008, found no benefit of additional arthrodesis 18 
after two years [8]. Similar results were shown in a Swiss multicenter study from 2017 of 185 19 
patients with LSS and spondylolisthesis after three years [22]. A recent Norwegian pragmatic 20 
comparative effectiveness study showed marginally better improvement (less than MCIC), of 21 
back pain among LSS patients with spondylolisthesis receiving decompression plus 22 
arthrodesis. No such association was found for ODI [23]. 23 
 24 
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We also found a large difference in the use of additional arthrodesis in patients without 1 
spondylolisthesis in 2011 – 2013. This treatment strategy has been discussed among spinal 2 
surgeons for many years, and is not in accordance with guidelines from 2013, where 3 
“decompression alone is suggested for patients with leg predominant symptoms without 4 
instability” [2, 4, 9]. The term “instability” is poorly defined, but has been linked to low back 5 
pain, a frequent symptom in LSS. This may explain the practice variation, also shown in a 6 
previous study where the arthrodesis rate in cases without spondylolisthesis was 29% in 7 
Boston (US), compared to only 6% in Norway [11]. We observed a rising rate of arthrodesis 8 
from Norway, via Sweden, to Denmark across the countries (Figure 2), but no corresponding 9 
trend (dose-response effect) in terms of higher treatment effectiveness (Table 3). In fact, the 10 
mean improvement of back pain in the spondylolisthesis group was somewhat higher in 11 
Norway (3.6) than in Denmark (2.7), which had the highest rate of arthrodesis (Figure 3). 12 
Hence, this study does not support the argument that arthrodesis prevents low back pain 13 
related to instability in spinal stenosis patients. The different frequency of multiple level 14 
surgery was small, and can neither explain the difference in the fusion rate, nor the lack of 15 
difference in outcome.  16 
 17 
We did both crude analysis and case mix analysis. Crude data shows small, not clinical 18 
relevant difference in the outcome between those with spondylolisthesis having 19 
decompression and fusion, but these differences vanished after the case mix adjustment (Table 20 
4). 21 
Fox et al. concluded in 1996 that radiological instability was common after decompression for 22 
degenerative LSS without spondylolisthesis, but correlated poorly with clinical outcome 23 
(back pain) [24]. The quality of some earlier studies advocating additional arthrodesis 24 
routinely is low due to small sample sizes, weak design, and outcome based on radiological 25 
Page 12 of 25
 13 
findings [25]. Moreover, a change towards using more minimally invasive decompression 1 
techniques may have reduced the risk for postoperative instability [26]. Previous studies show 2 
that arthrodesis adds higher risk of major complications, and even mortality [27]. Like 3 
Ghogawala et al., we found no association between the use of concomitant arthrodesis and 4 
surgeon reported complications [7]. 5 
 6 
Comorbidity rate in NORspine was physician-reported and higher compared to the patient-7 
reported rate in Swespine and DaneSpine. However, outcomes were similar, also when 8 
adjusting for comorbidity (Table 3). Between countries with larger diversity in demographic, 9 
socio-economic and cultural features, case mix adjustment may be more important. 10 
 11 
Even if the differences in effects sizes were smaller than considered as clinically relevant, 12 
subgroups of patients may benefit from additional arthrodesis. This should be investigated 13 
further in studies utilizing more precise data on radiological findings and with long term 14 
follow-up to assess reoperation rates. 15 
Quality assurance 16 
Loss to follow-up may bias the results. Two Scandinavian studies found that a loss to follow-17 
up of as high as 23% would not bias conclusions about overall treatment effects [28, 29]. 18 
They found, similar to our results, that non-responders were younger and more likely 19 
smokers. Therefore, it would be reasonable to assume that loss to follow up did not bias our 20 
results. 21 
Strength and limitations 22 
Register-based studies in general have advantages such as large sample sizes and high 23 
external validity, but also limitations due to lack of randomization, lower follow-up rates, and 24 
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lower internal validity compared to closely monitored clinical trials. In contrast to RCTs, this 1 
study allows surgeons and patients preferences to be included in a shared decision-making 2 
process prior to surgery, like in the “real world” of clinical practice. Still, there is increasing 3 
evidence in the literature that observational studies, conducted according to STROBE check 4 
list, report corresponding results similar to those found in RCTs [30]. 5 
There are limitations associated with this work. Even though registry data were collected 6 
prospectively for quality control and research, the hypotheses were decided on in retrospect. 7 
In addition, we did not have exact data on reoperation rates and only one-year follow-up. 8 
Reoperation rates may be as high as 20% at long term (3 to 5 years) [6], but previous studies 9 
have shown that clinical outcomes are stable up to 5 years [6].  10 
“In Scandinavia it is recommended to try conservative treatment prior to surgery for lumbar 11 
spinal stenosis. Previous studies show that the content of non-operative care is hard to define 12 
[31], and the effects of different conservative treatment alternatives are ambiguous. Since no 13 
uniform Scandinavian guidelines for such treatment exist, the type of preoperative 14 
conservative treatment was not recorded in the registries, only duration of symptoms.  15 
The use of the ICHOM concept and adding case mix analyses makes comparisons more 16 
credible, but a relative small set of baseline variables has been used for case mix adjustment.  17 
Page 14 of 25
 15 
CONCLUSION 1 
Real life data from three national spine registers showed similar indications for 2 
decompression surgery, but significant differences in the use of concomitant arthrodesis in 3 
Scandinavia. Additional arthrodesis was not associated with better treatment effectiveness. 4 
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Figure 1: Flowchart showing study enrolment. 49 
 50 
Figure 2: Four bar charts showing rate of arthrodesis in lumbar spinal stenosis with or without 51 
spondylolisthesis in Norway, Sweden, and Denmark.  52 
 53 
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Figure 3: Four bar charts showing the mean improvement in Oswestry Disability Index (ODI), 1 
Numeric rate score (NRS) leg pain, NRS back pain, and Euro-Qual – Five Dimensions (EQ-2 
5D) in patients without and with spondylolisthesis in Norway, Sweden, and Denmark. 3 
 4 
 5 
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Table 1 Baseline characteristics of patients operated in Norway, Sweden, and Denmark 1 
Total (n = 14223) 
Norway 
(n =3173 ) 
Sweden 
(n = 7389) 
Denmark 
(n = 3661) 
 (P-value) 





 (SD) 27.3 (4.3) 27.4 (4.1) 27.1 (4.4) 0.002
*
 
Females, n (%) 1701 (54%) 4075 (54%) 2006 (55%) 0.595
†
 
Smokers, n (%) 660 (21.1%) 678 (9.3%) 792 (22.0%) <0.001
†
 
Any comorbidity, n (%) 804 (25.4%) 591 (8.0%) 352 (9.6%) <0.001
†
 
    Neurological comorbidity, n (%) 76 (2.4%) 201 (2.8%) 84 (2.3%) 0.334
†
 
    Heart comorbidity, n (%) 686 (21.7%) 313 (4.3%) 201 (5.4%) <0.001
†
 
    Cancer comorbidity, n (%) 91 (2.9%) 77 (1.0%) 67 (1.8%) <0.001
†
 
Preoperative PROM     
   ODI (95%CI) 40 (39 to 40) 44 (43 to 44) 41 (40 to 41) <0.001
*
 
   NRS leg pain (95%CI) 6.6 (6.5 to 6.7) 6.4 (6.3 to 6.4) 5.8 (5.7 to 5.9) <0.001
*
 
   NRS back pain (95%CI) 6.4 (6.4 to 6.5) 5.6 (5.6 to 5.7) 5.1 (4.9 to 5.2) <0.001
*
 
   EQ-5D (95%CI) 0.37 (0.36 to 0.39) 0.37 (0.36 to 0.38) 0.42 (0.41 to 0.43) <0.001
*
 
Preoperative duration of leg pain >1 year, n (%) 3173 (68%) 4996 (68%) 3661 (55%) <0.001
†
 
Preoperative duration of back pain >1 year, n (%) 2470 (78%) 5567 (75%) 2473 (68%) <0.001
†
 
ODI = Oswestry Disability Index, NRS = Numeric Rating Scale, EQ-5D = Euro-Qol-5D 3 levels, BMI = Body Mass Index, 95%CI = 95% confidence interval 2 
*
ANOVA F-test 3 
 4 
†
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Table 2 - Baseline characteristics of responders and non-responders  1 
 
Total (n = 14223) 
Responders 
n = 10890 (77%) 
Non-responders 
n = 3333 (23%) P value 
Age, years (SD) 68.7 (8.8) 67.9 (9.7) <0.001
*
 
BMI, kg/m2 (SD) 27.3 (4.2) 27.4 (4.6) 0.297
*
 
Females, n (%) 5905 (54%) 1827 (55%) 0.360
†
 
Smokers, n (%) 1449 (14%) 681 (21%) <0.001
†
 
Any co-morbidity, n (%) 1299 (12%) 448 (13%) 0.020
†
 
    Neurological co-morbidity, n (%) 265 (2.4%) 96 (2.9%) 0.151
†
 
    Heart co-morbidity, n (%) 910 (8.4%) 290 (8.7%) 0.531
†
 
    Cancer co-morbidity, n (%) 166 (1.5%) 69 (2.1%) 0.031
†
 
Preoperative duration of leg pain >1 year, n (%) 7017 (64%) 2164 (65%) 0.604
†
 
Preoperative duration of back pain >1 year, n (%) 8032 (74%) 2478 (74%) 0.496
†
 
Preoperative PROM values 
   ODI (SD) 40 (16) 43 (16) <0.001* 
NRS leg pain (SD) 6.3 (2.5) 6.2 (2.6) 0.112
*
 
NRS back pain (SD) 5.6 (2.7) 5.7 (2.7) 0.205
*
 
EQ-5D (SD) 0.40 (0.31) 0.36 (0.32) <0.001
*
 
Data are shown as mean (SD), or number (%). P-values for comparison between responders and non-responders are shown. PROM = Patients Reported Outcome Measures.  2 
*
Student's t-test 3 
†
Pearson's Chi-square test 4 
 5 
 6 
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Table 3 Improvements in PROMs by country 1 
     
Total (n = 10890) 
Norway 
(n =2559 ) 
Sweden 
(n = 5990) 
Denmark 




ODI     
ODI, mean diff (95%CI) 18 (17 to 18) 17 (17 to 18) 18 (17 to 19) 0.081* 
ODI, mean diff case-mix adj (95%CI) 16 (16 to 17) 18 (18 to 19) 17 (17 to 17) 0.010* 
ODI % > MCIC (95%CI) 64 (62 to 66) 60 (59 to 61) 65 (63 to 68) <0.001
‡
 
ODI % ≤ 22 (95%CI) 64 (62 to 66) 64 (63 to 65) 64 (61 to 66) 0.837
‡
 
NRS leg pain     
NRS leg pain, mean diff (95%CI) 3.2 (3.1 to 3.4) 3.1 (3.0 to 3.2) 2.9 (2.7 to 3.1) 0.008* 
NRS leg pain, mean diff case-mix adj (95%CI) 3.2 (3.2 to 3.3) 3.2 (3.1 to 3.2) 2.7 (2.6 to 2.8) <0.001* 
NRS leg pain % > MCIC (95%CI) 64 (62 to 66) 63 (62 to 65) 66 (63 to 68) 0.263
‡
 
NRS back pain     
NRS back pain, mean diff (95%CI) 3.0 (2.9 to 3.2) 2.4 (2.3 to 2.4) 2.2 (2.0 to 2.3) <0.001* 
NRS back pain, mean diff case-mix adj (95%CI) 2.9 (2.9 to 3.0) 2.5 (2.4 to 2.5) 2.0 (2.0 to 2.1) <0.001* 
NRS back pain % > MCIC (95%CI) 64 (62 to 66) 61 (59 to 62) 62 (60 to 64) 0.038
‡
 
EQ-5D     
EQ-5D, mean diff (95%CI) 0.28 (0.26 to 0.29) 0.27 (0.26 to 0.28) 0.28 (0.26 to 0.29) 0.323* 
EQ-5D, mean diff case-mix adj (95%CI) 0.27 (0.26 to 0.28) 0.28 (0.28 to 0.29) 0.25 (0.24 to 0.26) <0.001* 
 
Data are shown as mean (95%CI), or % (95%CI)). P-values for comparison between the groups are shown. . PROMs = Patient Reported Outcome Measures  SD = Standard deviation, CI= 2 
Confidence interval, ODI = Oswestry Disability Index, NRS = Numeric Rating Scale, EQ-5D = Euro-Qol-5D 3 levels, MCIC = Minimal Clinically Important Change. Adjusted mean presented 3 
as predicted value.  *Anova F-test, † Student's t test,  
‡
Pearson's Chi-square test 4 
 5 
 6 
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Table 4: Improvements in PROMs by type of surgery in the combined cohort of Norway, Sweden and Denmark.  1 
 Mean outcome difference (95%CI) 
Crude ODI  NRS Leg Pain NRS Back Pain EQ-5D 
No spondylolisthesis     
 Decompression only (n=7791) 17 (17 to 18) 3.0 (2.9 to 3.0) 2.3 (2.3 to 2.4) 0.26 (0.25 to 0.27) 
 Decompression and arthrodesis (n=761) 18 (17 to 20) 3.0 (2.8 to 3.3) 2.7 (2.3 to 3.0) 0.29 (0.26 to 0.31) 
 p-value (Student’s t-test) 0.169 0.529 0.002 0.073 
Spondylolisthesis     
 Decompression only (n=925) 17 (16 to 18) 3.3 (3.1 to 3.5) 2.6 (2.3 to 2.8) 0.26 (0.24 to 0.29) 
 Decompression and arthrodesis (n=1413) 20 (19 to 21) 3.6 (3.4 to 3.8) 3.1 (3.0 to 3.3) 0.32 (0.31 to 0.34) 
 p-value (Student’s t-test) <0.001 0.029 <0.001 <0.001 
     
Case mix adjusted*     
No spondylolisthesis     
 Decompression only (n=7791) 17 (17 to 18) 3.1 (3.0 to 3.1) 2.4 (2.4 to 2.5) 0.27 (0.26 to 0.27) 
 Decompression and arthrodesis (n=761) 19 (18 to 20) 3.0 (2.9 to 3.2) 2.7 (2.6 to 2.9) 0.30 (0.29 to 0.32) 
 p-value (Student’s t-test) <0.001 0.710 <0.001 <0.001 
Spondylolisthesis     
 Decompression only (n=925) 17 (17 to 18) 3.2 (3.1 to 3.3) 2.5 (2.4 to 2.6) 0.27 (0.25 to 0.28) 
 Decompression and arthrodesis (n=1413) 18 (18 to 19) 3.2 (3.1 to 3.3) 2.6 (2.5 to 2.7) 0.29 (0.28 to 0.30) 
 p-value (Student’s t-test) 0.010 0.965 0.077 0.035 
     
*Data adjusted for age, gender, BMI, smoking, comorbidity, and baseline PROM values. PROMs = Patient Reported Outcome Measures, ODI = Oswestry Disability Index, NRS = Numeric 2 
Rating Scale, EQ-5D = Euro-Qol-5D 3 levels.  3 
 4 
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